1. On July 21, 2017, the Defendant paid to Plaintiff A KRW 21,00,000, KRW 9,000,000 for each of the above and each of the above amounts to Plaintiff B, C, and D.

1. Basic facts

A. On July 17, 2017, the Party F was hospitalized in G Hospital operated by the Defendant (hereinafter “Defendant Hospital”) and the Plaintiff’s spouse, and the rest of the Plaintiffs are lineal descendants of the Deceased, who were suffering from the urine urine and Professor H, for the eurology and the eurology for the eurine cancer (hereinafter “the instant surgery”) and were restored to the hospital on July 20, 2017, and were recovered from the hospital. However, on July 23:30, 2017, the Party F was temporarily recovered from the hospital.

B. On August 4, 2015, the Deceased’s death 1) began to undergo medical treatment from the above H on the suspicion of climatic urology and night therapy by having the Defendant’s hospital undergo emergency surgery and night therapy, following the Defendant’s urology. From October 8, 2015 to October 8, 2015, the Deceased participated in the clinical trial for “a-blocker (Tamsin 0.2mg) used for patients suffering from climatic urology” and “after the clinical trial for taking medicines for climatic 5mmmmc complex” conducted by the Defendant hospital (hereinafter “the Defendant hospital”).

) 2015. 11. 26. 망인의 병용 금기 약물 투약이 밝혀짐에 따라 임상시험에서 탈락하였다. 그 이후 망인은 2015. 12. 2., 2016. 3. 3., 2016. 6. 30., 2016. 9. 22., 2017. 3. 3. 각 H으로부터 전립선 비대증 및 급박뇨에 대한 치료를 받아왔다. 2) 망인은 2017. 6. 28. 서울 종로구 소재 ‘I내과’에서 CT 검사를 통하여 ‘왼쪽 신(腎)세포암 의심’ 진단을 받음과 아울러 혈뇨 양상을 보여 추가적인 검사와 진단을 받기 위하여 같은 날 피고 병원을 내원하였다.

Since then, the Deceased participated in the clinical trial of “an evaluation of usefulness of 11C-Mesthine PET/CT in kidam” implemented by the Defendant Hospital, and was subject to C&M inspection.

3 The Deceaseds, from the medical staff of the Defendant Hospital, conducted CT&M R tests on July 8, 2017, and on July 12, 2017, respectively.